OARS funding Cancer

This Funding Opportunity Announcement (FOA) announces an opportunity for eligible investigators receiving research funding from The National Institutes of Health (NIH) to request administrative supplement support. The "parent" awards and the proposed administrative supplements must be in areas of cancer, allergy, immunology, and/or infectious diseases (including HIV/AIDS and its co-morbidities). The overall goal of this supplement program is to enhance ongoing research efforts through collaborations with Brazilian scientists in these scientific areas under the new U.S.-Brazil Collaborative Biomedical Research Program.  

The Science of Science & Innovation Policy (SciSIP) program supports research designed to advance the scientific basis of science and innovation policy. Research funded by the program thus develops, improves and expands models, analytical tools, data and metrics that can be applied in the science policy decision making process.

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is seeking small grant (R03) applications to stimulate and facilitate the entry of promising new investigators into research on arthritis and musculoskeletal and skin diseases and injuries. This FOA will provide support for pilot research that is likely to lead to a subsequent individual research project grant (R01).

The goal of the Office of Science Graduate Student Research (SCGSR) program is to prepare graduate students for science, technology, engineering, or mathematics (STEM) careers critically important to the DOE Office of Science mission, by providing graduate thesis research opportunities at DOE laboratories.  The SCGSR program provides supplemental awards to outstanding U.S. graduate students to pursue part of their graduate thesis research at a DOE laboratory in areas that address scientific challenges central to the Office of Science mission. The research opportunity is expected to advance the graduate students' overall doctoral thesis while providing access to the expertise, resources, and capabilities available at the DOE laboratories.

The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer. The critical components of this award mechanism are: Impact: Research supported by the Breakthrough Award will have the potential for a major impact and accelerate progress toward ending breast cancer. The impact may be near-term or long-term, but must be significant and move beyond an incremental advancement. Applications must articulate the pathway to making a clinical impact for individuals with, or at risk for, breast cancer, even if clinical impact is not an immediate outcome. Research Scope: Research proposed under this award mechanism may be small- to large-scale projects, at different stages of idea and research development.

Call for Applications: Pancreatic Cancer Action Network - American Association for Cancer Research Career Development Award Supports a junior faculty member in developing or strengthening their pancreatic cancer research

Alex's Lemonade Stand Foundation Epidemiology Grants are $100,000 per year for two years. Funding is expected to allow investigators to pursue epidemiological approaches to significantly add to the understanding of childhood cancers. These awards are expected to provide funds that will support investigators pursuing epidemiological research aimed at improving our understanding of childhood cancer. This grant mechanism is designed to support hypothesis-driven research that focuses on the epidemiology, early detection and prevention of childhood cancer or comparative effectiveness and outcomes research related to detection, prevention and treatment.

Alex's Lemonade Stand Foundation (ALSF) is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. Innovation grants are designed as seed funding for researchers with a novel approach to pediatric oncology scientific investigation. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator's prior research but has potential impact for childhood cancers. Innovation Grants will support research proposals to be carried out by investigators who are already established, have a track record of peer-reviewed publications and evidence of successfully competing for extramural funding. The grant is for two years up to $125,000 per year. A one year no cost extension is encouraged.

This Funding Opportunity Announcement (FOA) announces an opportunity for eligible investigators receiving research funding from The National Institutes of Health (NIH) to request administrative supplement support. The parent awards and the proposed administrative supplements must be in areas of cancer, allergy, immunology, and/or infectious diseases (including HIV/AIDS and its co-morbidities). The overall goal of this supplement program is to enhance ongoing research efforts through collaborations with Brazilian scientists in these scientific areas under the new U.S.-Brazil Collaborative Biomedical Research Program.

The program is designed to bring together diverse interdisciplinary groups with expertise in genetics/genomics, immunology, microbiology, and proteomics along with the more traditional areas of parturition research such as maternal fetal medicine, obstetrics, and pediatrics to address scientific issues related to preterm birth. The fund has committed $3 million for the initiative and anticipates awarding five grants of up to $600,000 over a four-year period ($150,000 per year).

The Glaucoma Foundation works to encourage and support basic and applied research in glaucoma,  gain and disseminate new information about the causes and treatment of glaucoma, and  further efforts to identify and develop novel approaches to preserve visual function and reverse blindness caused by glaucoma.

Grants distributed from Alex's Lemonade Stand Foundation are designed to fill critical voids in current pediatric cancer research.

What do you get when you mix the view and excitement of Baltimore's Inner Harbor with about 700 grant administrators and researchers from around the world, then add more than 40 NIH and HHS experts in in one location who are eager to share their experiences and knowledge of the NIH grants process? You get the 2014 NIH Regional Seminar on Program Funding and Grants Administration, of course! Once again, "Charm City" will be the location for this once-a-year event June 25-27 at the Renaissance Baltimore Harborplace Hotel. Don't miss this exciting opportunity for investigators, administrators, grant writers and others who are new to the NIH grants process and/or those wanting to hear the latest NIH grants policy and process information first-hand. Learn how to successfully submit an application, navigate on-line resources, gain a better understanding of the peer review process, and hear about the expectations for managing your award.

The National Institutes of Health (NIH) awards senior individual research training fellowships to experienced scientists who wish to make major changes in the direction of their research careers or who wish to broaden their scientific background by acquiring new research capabilities as independent investigators in research fields relevant to the missions of participating NIH Institutes and Centers.

The purpose of the Kirschstein-NRSA postdoctoral fellowship is to enhance the research training of promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers.

The purpose of the Kirschstein-NRSA predoctoral fellowship (F31) award is to enable promising predoctoral students to obtain individualized, mentored research training from outstanding faculty sponsors while conducting dissertation research in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The proposed mentored research training must reflect the applicants dissertation research project and is expected to clearly enhance the individuals potential to develop into a productive, independent research scientist.

This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services.  Consistent with the goals of this funding initiative and as required by the SF424 instructions for all Phase II SBIR applications, applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.  

The L'Oréal USA For Women in Science fellowship program is a national awards program that annually recognizes and rewards five U.S.-based women researchers at the beginning of their scientific careers. Recipients receive up to $60,000 each that they must put towards their postdoctoral research. The program's partner, AAAS, manages the peer-review process. Launched in 2003 as the U.S. Fellowships component of the L'Oréal-UNESCO For Women in Science International Fellowship program, the program aim to: Raise awareness of the contribution of women to the sciences Identify exceptional female researchers in the U.S. to serve as role models for younger generations An inter-disciplinary panel of scientists reviews all applications submitted. The top candidates chosen by the review panel are then forwarded for final selection to a distinguished Jury of career scientists and former North American L'ORÉAL-UNESCO For Women in Science Laureates. The Jury seeks candidates with exceptional academic records and intellectual merit, clearly articulated research proposals with the potential for scientific advancement and outstanding letters of recommendation from advisers. New to the program this year, applicants will also be evaluated in part on their commitment to supporting women and girls in science.

The signature funding initiative of the Research Awards Program (RAP), is the CLARIONS Grant Program, which stands for Curing Cutaneous Lymphoma by Advancing Research, Innovation and Offering New Solutions.  This research grant program supports investigators interested in conducting innovative cutaneous lymphoma research.   These grants will help uncover causes and improve the treatment and quality of life for patients. Discovering new avenues for better therapies and, one day, a cure for cutaneous lymphoma are key goals of this program.

This fall, OARS will host a series of brown-bag workshops on navigating the NSF proposal process.  Workshops will be held select Tuesdays from noon to 1:00pm in Pearson 208.  You are welcome to attend any or all of the sessions.  Click through for dates and registration information.